GSK Investigational Site

Exeter EX2 5DW

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Cerebrovascular Accident, Kidney Disease, Ovarian Neoplasms

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease — Running, not enrolling
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Proof of Concept (POC) in Patients With Ischaemic Stroke — Stopped early